Abstract:Mohammed Alkhaldi, 1– 4 Aisha Al Basuoni, 5 Márcia Matos, 1 Marcel Tanner, 2, 3 Sara Ahmed 1 1 School of Physical and Occupational Therapy, Faculty of Medicine, McGill University, Montreal, Canada; 2 Department of Public Health, University of Basel, Basel, Switzerland; 3 The Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland; 4 Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine; 5 Projects Unit, Gaza Community Mental Health Programme, Gaza, Palestine Correspondence: Mohammed Alkhaldi Email Technological innovation has a significant role in improving health systems (HSs) and achieving universal health coverage (UHC). The World Health Organization (WHO) has declared resolutions on Health Technology Assessment (HTA) and other global organizations emphasized on HTA systems to achieve the Sustainable Development Goals (SDGs). HTA is a modern multidisciplinary decision-making framework linking knowledge and policymaking by assessing the medical, social, economic, organizational, and ethical effects, and/or impacts within health and social systems. The research significance lies in the growing need for HTA at these moments than ever as it is seen as an essential development approach to tackle the current global challenges and pandemics, particularly in developing countries. The research aims to comprehensively evaluate and understand HTA systems concerning the level of knowledge about HTA, current HTA structure, practices, application, capacity, gaps, and solutions. The project starts in January 2021 and ends in January 2022 and will be carried out in seven countries: Canada, Switzerland, Brazil, Lebanon, Jordan, Palestine, and Tanzania. A mixed-methods, quantitative and qualitative, along with a literature review will be applied. In each country, ten HTA-associated institutions will complete an adapted electronic survey, developed by the WHO, and ten key-informants selected purposively from the government, academia, NGOs, and private sectors to participate in ten individual in-depth interviews. One government representative from each country will participate in one expanded inter-country workshop. Excel, IBM Statistical Package for the Social Sciences (SPSS), and MAXQDA software programs will be used for data management and analysis. The research will form cutting-edge evidence not only for the seven countries, but also for the global, regional, and national endeavors with regards to opening a room for HTA best application and optimization. It will reveal lessons learned, determine gaps, and build a well-enabled and institutionalized HTA for better UHC, health systems, and multi-sectoral development. Keywords: HTA systems, health systems, health policy and decision-making, HMLICs Technological innovation has a significant role in improving healthcare delivery and universal health coverage, where the World Health Organization (WHO) and other global health organizations emphasize supporting regional and national Health Technology Assessment (HTA) systems. A growing interest in HTA and its eventual institutionalization in low and middle-income countries (LMICs) is driven in part by WHO's recommendation for it to be a critical component to achieving UHC. 1 Integrating HTA within a country's health innovation system would help in the smooth convergence of technology, innovation and policy for addressing systemic gaps. 2 HTA is immensely increasing not only in developed countries but also in developing countries. It reduces resource waste, inefficiencies, and inappropriate investments in Health Systems (HSs). As being a tool for a strategy of evidence-based decision-making, HTA can help address issues relating to both affordability and equity when allocating resources. 3 HTA is a multidisciplinary decision-making process that uses information about the medical, social, economic, organizational, and ethical issues related to the use of growing health technologies and interventions such as information and communication technology, E-Health, electronic health records, medical devices, diagnostic devices, clinical interventions, medicines, vaccines, and practice management solutions. HTA involves a rigorous review of new technologies, not just in terms of their added clinical utility but also often with an eye toward cost-effectiveness. Assessing the effectiveness and optimal utilization of these interventions within the health and social systems using sound methodological evaluation, assessments, and analyses like HTA is indispensable before being introduced into practice. <a href="#cit0004%20cit0005%20cit0006 -Abstract Truncated-

Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters' countries

Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges

Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries

Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe

Regulatory intelligence of health technologies in Greece

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries

OP104 Moving Forward Hospital-Based Health Technology Assessment: Public Procurement Of Innovation

Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus

The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan—Implications for the Evaluation of Diabetes Mellitus Therapies

A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DM

1614-P: Targeting People with Unknown Diabetes in Health Insurance Databases through Artificial Intelligence

International practices in health technology assessment and public financing of digital health technologies: recommendations for Hungary

Usability and acceptance of a digital screening tool for diabetes in four European countries: the DigiCare4You study

Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report

Addressing chronic diseases: a comparative study of policies towards type-2 diabetes and hypertension in selected European countries

Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data

Implementation of Integrated Primary Care for Patients with Diabetes and Hypertension: A Case from Slovenia

Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks

Health Technology Assessment in High, Middle, and Low-income Countries: New Systematic and Interdisciplinary Approach For Sound Informed-policy Making: Research Protocole

A blueprint for health technology assessment capacity building: lessons learned from Malta

Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process